Abstract
The authors describe a patient treated 16 years by phenylbutazone for ankylosing spondylarthritis and in whom appeared an IgA multiple myeloma with a Kappa light chain. This pathological association is rare and we can wonder about the respective etiopathological roles of spondylarthritis and its treatment by phenylbutazone in the occurrence of multiple myeloma.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Humans
-
Immunoglobulin A / biosynthesis
-
Immunoglobulin kappa-Chains / biosynthesis
-
Male
-
Middle Aged
-
Multiple Myeloma / complications*
-
Multiple Myeloma / immunology
-
Phenylbutazone / adverse effects
-
Phenylbutazone / therapeutic use
-
Spondylitis, Ankylosing / complications*
-
Spondylitis, Ankylosing / drug therapy
Substances
-
Immunoglobulin A
-
Immunoglobulin kappa-Chains
-
Phenylbutazone